TY - JOUR
TI - Vitamin D and COVID-19
AU - Trovas, G.
AU - Tournis, S.
JO - Vitamins and Hormones
PY - 2021
VL - 20
TODO - 1
SP - 207-208
PB - Springer Science and Business Media Deutschland GmbH
SN - null
TODO - 10.1007/s42000-020-00231-9
TODO - vitamin D;  vitamin D, clinical outcome;  coronavirus disease 2019;  disease association;  disease severity;  hospitalization;  human;  immune response;  mortality rate;  Note;  prevalence;  vitamin blood level;  vitamin D deficiency;  vitamin supplementation;  complication;  prevention and control;  vitamin D deficiency, COVID-19;  Humans;  SARS-CoV-2;  Vitamin D;  Vitamin D Deficiency
TODO - Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections. © 2020, Hellenic Endocrine Society.
ER -